BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2594002)

  • 21. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study.
    Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y
    Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.
    Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y
    Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical demonstration of chromogranin in endometrial carcinomas with argyrophilia.
    Ueda G; Tanaka Y; Inoue Y; Nishino T; Saito J; Abe Y; Shimizu H; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2853-4. PubMed ID: 2418138
    [No Abstract]   [Full Text] [Related]  

  • 25. Cholinergic nerve terminals in the rat diaphragm are chromogranin A immunoreactive.
    Volknandt W; Schober M; Fischer-Colbrie R; Zimmermann H; Winkler H
    Neurosci Lett; 1987 Oct; 81(3):241-4. PubMed ID: 3431741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural identification of human secretin cells by the immunogold technique. Their costorage of chromogranin A and serotonin.
    Usellini L; Finzi G; Riva C; Capella C; Mochizuki T; Yanaihara C; Yanaihara N; Solcia E
    Histochemistry; 1990; 94(2):113-20. PubMed ID: 1972699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine cells and prognosis in patients with colorectal carcinoma.
    Hamada Y; Oishi A; Shoji T; Takada H; Yamamura M; Hioki K; Yamamoto M
    Cancer; 1992 Jun; 69(11):2641-6. PubMed ID: 1571893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromogranin positive cells in colorectal carcinoma and transitional mucosa.
    Mori M; Mimori K; Kamakura T; Adachi Y; Ikeda Y; Sugimachi K
    J Clin Pathol; 1995 Aug; 48(8):754-8. PubMed ID: 7560204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glassy cell carcinoma of the colon with human chorionic gonadotropin-production. A case report with immunohistochemical and ultrastructural analysis.
    Aru A; Rasmussen LA; Federspiel B; Horn T
    Am J Surg Pathol; 1996 Feb; 20(2):187-92. PubMed ID: 8554108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neuroendocrine marker in tissues of the immune system.
    Angeletti RH; Hickey WF
    Science; 1985 Oct; 230(4721):89-90. PubMed ID: 3898368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of chromogranin containing cells in the porcine gastroenteropancreatic endocrine system.
    Ito H; Hashimoto Y; Kitagawa H; Kon Y; Kudo N
    Nihon Juigaku Zasshi; 1988 Apr; 50(2):395-404. PubMed ID: 3386095
    [No Abstract]   [Full Text] [Related]  

  • 32. A 10-year survey of large bowel carcinoma at Groote Schuur Hospital with particular reference to patients under 30 years of age.
    Elliot MS; Louw JH
    Br J Surg; 1979 Sep; 66(9):621-4. PubMed ID: 497646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer of the large bowel. Practical value of classification.
    Valdés-Dapena A
    Cancer; 1971 Jul; 28(1):103-8. PubMed ID: 5110613
    [No Abstract]   [Full Text] [Related]  

  • 34. Carcinoma of the large bowel; prognosis from the standpoint of cell differentiation.
    HENDRICKS WA
    Q Bull Northwest Univ Med Sch; 1949; 23(3):296-304. PubMed ID: 18136540
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Use of historic controls in cancer studies.
    Wood CB; Gillis CR; Blumgart LH
    Lancet; 1976 Jul; 2(7979):251-2. PubMed ID: 59256
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunohistochemical and clinicopathological studies of chromogranin immunoreactive cells in large bowel carcinoma].
    Oishi A
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1742-51. PubMed ID: 2594002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma.
    Arends JW; Wiggers T; Verstijnen K; Bosman FT
    J Pathol; 1986 Jun; 149(2):97-102. PubMed ID: 3525789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromogranins A and B and secretogranin II in hormonally identified endocrine cells of the gut and the pancreas.
    Buffa R; Marè P; Gini A; Salvadore M
    Basic Appl Histochem; 1988; 32(4):471-84. PubMed ID: 3223865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
    Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
    Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.